Development and Validation of a Combined Ferroptosis and Immune Prognostic Classifier for Hepatocellular Carcinoma

BACKGROUND: Immunotherapy and sorafenib exert anti-tumor effects via ferroptosis, but reliable biomarkers for the individual treatment and prognosis prediction of hepatocellular carcinoma (HCC) based on the ferroptosis and immune status remain lacking. METHODS: Ferroptosis-related genes (FRGs) were...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yang, Zhang, Xi, Zhang, Junjun, Tan, Juan, Li, Jie, Song, Zewen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Cell and Developmental Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7785857/
https://www.ncbi.nlm.nih.gov/pubmed/33425905
http://dx.doi.org/10.3389/fcell.2020.596679

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7785857/
https://www.ncbi.nlm.nih.gov/pubmed/33425905
http://dx.doi.org/10.3389/fcell.2020.596679

Ejemplares similares